Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 350
Filter
1.
Washington; Organización Panamericana de la Salud; july 8, 2020. 11 p.
Non-conventional in Spanish | LILACS, Inca | ID: biblio-1102945

ABSTRACT

Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en 4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales (1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y los betacoronavirus OC43 y HKU1 que pueden causar enfermedades de tipo influenza o neumonía en humanos (1, 3). Sin embargo, dos coronavirus zoonóticos que causan enfermedades graves en humanos han emergido: el coronavirus del Síndrome respiratorio agudo grave (SARS-CoV) en 2002-2003 y el coronavirus del Síndrome respiratorio de Oriente Medio (MERS-CoV) (1-5). En enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo betacoronavirus, distinto del SARS-CoV y MERS-CoV (6). El 11 de febrero de 2020, el Comité Internacional de Taxonomía de Virus (ICTV) anunció la denominación del virus como coronavirus del síndrome respiratorio agudo grave 2 (SARS-CoV-2) (7), mientras que, el mismo día, la OMS nombró la enfermedad como enfermedad por coronavirus COVID-19 (8). Para fines de comunicación, haremos referencia a este virus como "el virus responsable de COVID-19" o "el virus COVID-19". La secuencia genómica completa de este nuevo agente está disponible y se han desarrollado diferentes protocolos de detección (9). A la luz de la circulación actual de COVID-19 en la región de las Américas, la Organización Panamericana de la Salud / Organización Mundial de la Salud (OPS / OMS) recomienda a los Estados Miembros garantizar la identificación oportuna de casos sospechosos, la toma y el envío de muestras a los laboratorios de referencia, y la implementación de protocolos de detección molecular, según la capacidad del laboratorio.


Subject(s)
Pneumonia, Viral/diagnosis , Specimen Handling/standards , Coronavirus Infections/diagnosis , Clinical Laboratory Techniques/standards , Clinical Enzyme Tests/standards , RNA/standards , Polymerase Chain Reaction/standards , Personal Protective Equipment/standards , Betacoronavirus
2.
Rev. bras. anal. clin ; 51(2): 103-106, 20191011.
Article in Portuguese | LILACS | ID: biblio-1024821

ABSTRACT

É uma doença infecciosa causada por um protozoário parasita chamado Trypanosoma cruzi,nome dado por seu descobridor, o cientista brasileiro Carlos Chagas, em homenagem a outro cientista, também brasileiro, Oswaldo Cruz. Essa doença é conhecida popularmente como doença do coração crescido, além disso, os locais com mais índices dessa doença são as regiões do Norte e Sudeste e tem como formas de diagnósticos exames de sorologiaparasitários e xenodiagnóstico. E uma das principais formas de prevenção da doença vem sendo o uso de telas e repelentes.


It is an infectious disease caused by a protozoan parasite calledTrypanosoma cruzi, named after its discoverer, the Brazilian scientistCarlos Chagas, in honor of another scientist, also, Brazilian, Oswaldo Cruz. This disease is popularly known as a disease of the heart grown, in addition, the sites with the most indexes of this disease are the regions of the North and southeast and have as diagnostic methods serologica tests parasitic and xenodiagnosis. And one of the main forms of prevention of the disease has been the use of screens and repellents.


Subject(s)
Trypanosoma cruzi , Chagas Disease/etiology , Chagas Disease/physiopathology , Chagas Disease/prevention & control , Chagas Disease/therapy , Chagas Disease/epidemiology , Clinical Enzyme Tests
3.
rev. cuid. (Bucaramanga. 2010) ; 9(3): 2387-2399, sep.-dic. 2018. tab, graf
Article in Portuguese | ColecionaSUS, LILACS, BDENF, ColecionaSUS, COLNAL | ID: biblio-979569

ABSTRACT

Resumo Introdução Hábitos alimentares inadequados na infância predispõem ao surgimento de doenças metabólicas na fase adulta, objetivando a identificar alterações de IMC em escolares no município de Poços de Caldas-MG-BR, com idades entre 6 a 12 anos, avaliar análises bioquímicas, dados antropométricos e padrão alimentar. Material e Métodos Estudo quantitativo de campo, desenvolvido em três escolas, uma de ensino público e duas de ensino privado, no período de 2015 a 2016, com amostragem de 104 crianças. As variáveis de interesse foram dados antropométricos, amostragem sanguínea para exames laboratoriais e formulário de padrão alimentar. Resultados: A idade média da amostra foi 9,5±0,2, sendo 53,9% meninos e 46,2% meninas. Entre as prevalências encontradas, 51,0% das crianças tiveram algum tipo de alteração no IMC, sendo 29,2% de obesidade e 25,0% de sobrepeso na escola particular frente a 6,3% obesidade e 15,6% sobrepeso na escola pública. Observou que 60,6% apresentam alteração para glicemia em jejum (113,1±1,4 mg/dl). Colesterol 51,9% de alteração (196,0±2,9 mg/dl), HDL 43,3% mostram alterados (40,5±0,4 mg/dl), LDL percebe 19,2% das crianças apresentam aumento do valor normal (143,6±4,0 mg/dl) e TG 20,2% acima do valor recomendado (158,8±10,7 mg/dl). Foi possível observar ainda uma alta significantemente estatística na ingesta alimentar dando prioridade ao grupo de açúcares. Discussão A amostra estudada apresenta alterações significativas para sobrepeso e obesidade, bem como para valores de porções alimentares, glicemia e dislipidemias. Conclusões Mostra-se importante estudo na área a fim de mapear e melhorar o perfil nutricional para diminuir os riscos aos quais as crianças estão expostas.


Abstract Introduction Inadequate eating habits in childhood predispose to the onset of metabolic diseases in adulthood, aiming to identify changes in BMI in schoolchildren in the municipality of Poços de Caldas, MG, Brazil, aged 6 to 12 years, and to evaluate biochemical analyzes, anthropometric data and food patterns. Materials and Methods A quantitative field study, developed in three schools, one public and two private schools, from 2015 to 2016, with a sample of 104 children. The variables of interest for the study were anthropometric data, blood sampling for laboratory tests and food patterns form. Results The average age of the sample was 9.5 ± 0.2, with 53.9% boys and 46.2% girls. Among the prevalence found, 51.0% of the children had some type of alteration in BMI, being 29.2% of obesity and 25,0% of overweight in private school, compared to 6.3% of obesity and 15.6% of overweight in public school. Observed that 60.6% presented alteration to fasting glycaemia (113.1±1.4 mg/dl). Alteration of 51,9% in Cholesterol (196,0±2,9 mg/dl), HDL 43,3% altered (40,5±0,4 mg/dl), the value of LDL indicate that 19,23% of the children increased of the normal value (143,6±4,0 mg/dl) and TG 20,2% is above the recommended value (158,8±10,7 mg/dl). It was also possible to observe a statistically significant increase in food intake giving priority to the sugar group. Discussion The sample studied, presented significant alterations for overweight and obesity, as well as for food portions, glycaemia and dyslipidemia. Conclusions It seems important studies in the area are necessary to map and improve the nutritional profile to reduce the risks to which children are exposed.


Resumen Introducción Los hábitos alimenticios inadecuados en la infancia predisponen al surgimiento de enfermedades metabólicas en la fase adulta, por ello, este estudio tiene por objeto identificar los cambios del IMC en alumnos del municipio de Poços de Caldas-MGBR, con edades de 6 a 12 años, así como evaluar análisis bioquímicos, datos antropométricos y patrones de alimentación. Materiales y Métodos: Estudio cuantitativo de campo, desarrollado en tres escuelas, una pública y dos privadas, en el período 2015- 2016, con un muestreo de 104 niños. Las variables de interés correspondieron a datos antropométricos, muestreo sanguíneo para exámenes de laboratorio y formulario de patrones alimenticios. Resultados La edad promedio de la amuestra fue de 9,5±0,2, con 53,9% de niños y 46,2% de niñas. Entre las prevalencias encontradas, 51 ,0% de los infantes tuvieron algún tipo de cambio en el IMC, de los cuales 29,2 correspondía a obesidad y 25,0% a sobrepeso en las escuelas privadas versus 6,3% de obesidad y 15,6% de sobrepeso en la escuela pública. Se observó que 60,6% presentan una alteración de la glicemia en ayunas (113,1±1,4 mg/dl). Colesterol 51,9% de alteración (196,0±2,9 mg/dl), HDL con 43,3% de resultados con alteraciones (40,5±0,4 mg/dl), LDL de 19,2% de los infantes que presentan aumento del valor normal (143,6±4,0 mg/dl) y TG 20,2% por encima del valor recomendado (158,8±10,7 mg/dl). Igualmente, se pudo observar un alza significativamente estadística en la ingesta de alimentos, con prioridad para el grupo de azúcares. Discusión La muestra estudiada presenta alteraciones significativas para sobrepeso y obesidad, así como valores de porciones alimenticias, glicemia y dislipidemias. Conclusiones El estudio en esta área resulta importante con el fin de mapear y mejorar el perfil nutricional para disminuir los riesgos a los que están expuestos los niños y niñas.


Subject(s)
Humans , Male , Female , Child Nutrition Disorders , Body Mass Index , Child Nutrition , Pediatric Obesity , Clinical Enzyme Tests
4.
Rev. Soc. Bras. Med. Trop ; 50(4): 550-553, July-Aug. 2017. tab
Article in English | LILACS | ID: biblio-1041420

ABSTRACT

Abstract INTRODUCTION: This study aimed to evaluate a new commercial kit, Kit SIRE Nitratase-PlastLabor, for testing the drug susceptibility of clinical Mycobacterium tuberculosis isolates. METHODS: The accuracy of the Kit SIRE Nitratase was evaluated by examining the susceptibility (streptomycin, isoniazid, rifampicin, and ethambutol) of 40 M. tuberculosis isolates, using the proportion method with Lowenstein-Jensen medium or the BACTEC MGIT 960 system. RESULTS: The detection accuracy for streptomycin, isoniazid, rifampicin, and ethambutol was 95%, 97.5%, 100%, and 80%, respectively. CONCLUSIONS: The exceptional accuracy demonstrated by Kit SIRE Nitratase for isoniazid and rifampicin makes the kit an attractive option for screening M. tuberculosis strain resistance.


Subject(s)
Humans , Oxidoreductases/pharmacology , Microbial Sensitivity Tests/methods , Antibiotics, Antitubercular/pharmacology , Mycobacterium tuberculosis/drug effects , Rifampin/pharmacology , Streptomycin/pharmacology , Reproducibility of Results , Drug Resistance, Bacterial , Clinical Enzyme Tests/methods , Ethambutol/pharmacology , Isoniazid/pharmacology , Mycobacterium tuberculosis/isolation & purification
5.
Ann. hepatol ; 16(3): 349-357, May.-Jun. 2017. tab, graf
Article in English | LILACS | ID: biblio-887246

ABSTRACT

ABSTRACT Background and rationale. Many different non-invasive methods have been studied with the purpose of staging liver fibrosis. The objective of this study was verifying if transient elastography is superior to aspartate aminotransferase to platelet ratio index for staging fibrosis in patients with chronic hepatitis C. Material and methods. A systematic review with meta-analysis of studies which evaluated both non-invasive tests and used biopsy as the reference standard was performed. A random-effects model was used, anticipating heterogeneity among studies. Diagnostic odds ratio was the main effect measure, and summary receiver operating characteristic curves were created. A sensitivity analysis was planned, in which the meta-analysis would be repeated excluding each study at a time. Results. Eight studies were included in the meta-analysis. Regarding the prediction of significant fibrosis, transient elastography and aspartate aminotransferase to platelet ratio index had diagnostic odds ratios of 11.70 (95% confidence interval = 7.13-19.21) and 8.56 (95% confidence interval = 4.90-14.94) respectively. Concerning the prediction of cirrhosis, transient elastography and aspartate aminotransferase to platelet ratio index had diagnostic odds ratios of 66.49 (95% confidence interval = 23.71- 186.48) and 7.47 (95% confidence interval = 4.88-11.43) respectively. Conclusion. In conclusion, there was no evidence of significant superiority of transient elastography over aspartate aminotransferase to platelet ratio index regarding the prediction of significant fibrosis, but the former proved to be better than the latter concerning prediction of cirrhosis.


Subject(s)
Humans , Aspartate Aminotransferases/blood , Hepatitis C/blood , Hepatitis C/diagnostic imaging , Clinical Enzyme Tests/methods , Elasticity Imaging Techniques/methods , Liver Cirrhosis/blood , Liver Cirrhosis/diagnostic imaging , Platelet Count , Prognosis , Biopsy , Severity of Illness Index , Biomarkers/blood , Odds Ratio , Predictive Value of Tests , Reproducibility of Results , ROC Curve , Hepatitis C/virology , Area Under Curve , Liver Cirrhosis/virology
7.
National Journal of Andrology ; (12): 786-792, 2017.
Article in Chinese | WPRIM | ID: wpr-812878

ABSTRACT

Objective@#To investigate the value of the content of neutrophil elastase (NE) in the expressed prostatic secretion (EPS) and seminal plasma (SP) as a combined predictor in the diagnosis of type IIIA prostatitis with secondary infertility.@*METHODS@#This study included 62 fathers (group A) and 67 infertile men (group B), all with type IIIA prostatitis, and another 57 controls with no genitourinary tract disease (group C). We measured the NE contents in the EPS and SP, obtained the results of routine semen and EPS examinations and Chronic Prostatitis Symptom Index (CPSI), and calculated the ratio of EPS NE/SP NE by binary logistic regression analysis.@*RESULTS@#The combined predictor of type IIIA prostatitis with secondary infertility was SP NE-2 × EPS NE. Among the 129 patients with type IIIA prostatitis, the combined predictor was correlated strongly negatively with the WBC count in the EPS (r = -0.914, P 0.05). The mean values of the combined predictor in groups A, B, and C were -2 238 (95% CI: -2 595 to -2 054), -1 511 (95% CI: -1 778 to -1 307), and -148 (95% CI: -181 to -118), respectively, with statistically significant differences between the cases and controls as well as between groups A and B (P <0.01). The area under the ROC curve of the combined predictor for the diagnosis of type IIIA prostatitis with secondary infertility was 0.71 (P <0.001).@*CONCLUSIONS@#The content of neutrophil elastase in the EPS combined with that in the seminal plasma contributes to the diagnosis of type IIIA prostatitis with secondary infertility, which is superior to either the neutrophil elastase content in the EPS or that in the seminal plasma used alone.


Subject(s)
Biomarkers , Chronic Disease , Clinical Enzyme Tests , Methods , Fathers , Humans , Infertility , Diagnosis , Leukocyte Elastase , Male , Prostatitis , Diagnosis , Semen , Semen Analysis , Sperm Motility
8.
Arq. bras. med. vet. zootec ; 68(4): 839-844, jul.-ago. 2016. tab
Article in Portuguese | LILACS, VETINDEX | ID: lil-792456

ABSTRACT

Amostras de sangue foram obtidas de 138 equinos registrados da raça Campeiro, com idade média de 9,7±5,4 anos, sendo 14 machos (10,15%) e 124 fêmeas (89,85%). Observaram-se valores médios da atividade sérica de GGT: 13,73±4,08 U/L; AST: 246,34±72,87U/L; ALT: 5,13±1,18U/L; FA: 284,32±53,33UI/L; CK: 132,54±72,25U/L; LDH: 511,38±143,65U/L; e das concentrações séricas de ureia: 38,65±12,62mg/dL e de creatinina: 1,24±0,24mg/dL. Os valores médios de AST, FA, ALT, ureia e creatinina foram semelhantes aos propostos na literatura para outras raças. Os valores de CK, GGT e LDH foram superiores aos comumente utilizados como referências. Não houve diferença nas concentrações de nenhum dos componentes séricos avaliados nas diferentes idades analisadas. Maiores valores médios nas concentrações de ureia e menores de creatinina foram observados nas fêmeas em relação aos machos, assim como a maior atividade sérica de FA em fêmeas gestantes em relação às éguas vazias. O perfil bioquímico sérico de equinos sadios da raça Campeiro apresenta variações peculiares que devem ser levadas em consideração na interpretação de exames laboratoriais.(AU)


Blood samples were obtained from 138 equines of the Campeiro breed with mean ages of 9.7±5.4 years, including 14 males (10.15%) and 124 mares (89.85%). Mean values of serum of GGT: 13.73 ± 4.08U/L; AST: 246.34±72.87U/L; ALT 5.13±1.18U/L; FA: 284.32±53.33IU/L; CK: 132.54±72.25U/L; LDH: 511.38±143.65U/L; and serum urea: 38.65±12.62mg/dL and creatinine: 1.24±0.24mg/dL were observed. The mean values of AST, FA, ALT, urea and creatinine were similar to those proposed in the literature for other breeds. The CK values, GGT, and LDH were higher than those commonly used as references. There was no difference in the concentrations of any of the serum components evaluated at different ages analyzed. Further average values in the lower urea concentrations and creatinine were observed in females compared to males, as well as the higher serum activity of FA in pregnant mares in relation to non-pregnant. Serum biochemical profile of healthy horses of the Campeiro breed presents peculiar variations that must be taken into consideration in the interpretation of laboratory tests.(AU)


Subject(s)
Animals , Male , Female , Pregnancy , Clinical Enzyme Tests/veterinary , Horses/blood , Clinical Laboratory Techniques/veterinary
9.
Clinics ; 71(5): 271-275, May 2016. tab, graf
Article in English | LILACS | ID: lil-782841

ABSTRACT

OBJECTIVES: Delay in the treatment of pleural infection may contribute to its high mortality. In this retrospective study, we aimed to evaluate the diagnostic accuracy of pleural adenosine deaminase in discrimination between Gram-negative and Gram-positive bacterial infections of the pleural space prior to selecting antibiotics. METHODS: A total of 76 patients were enrolled and grouped into subgroups according to Gram staining: 1) patients with Gram-negative bacterial infections, aged 53.2±18.6 years old, of whom 44.7% had empyemas and 2) patients with Gram-positive bacterial infections, aged 53.5±21.5 years old, of whom 63.1% had empyemas. The pleural effusion was sampled by thoracocentesis and then sent for adenosine deaminase testing, biochemical testing and microbiological culture. The Mann-Whitney U test was used to examine the differences in adenosine deaminase levels between the groups. Correlations between adenosine deaminase and specified variables were also quantified using Spearman’s correlation coefficient. Moreover, receiver operator characteristic analysis was performed to evaluate the diagnostic accuracy of pleural effusion adenosine deaminase. RESULTS: Mean pleural adenosine deaminase levels differed significantly between Gram-negative and Gram-positive bacterial infections of the pleural space (191.8±32.1 U/L vs 81.0±16.9 U/L, p<0.01). The area under the receiver operator characteristic curve was 0.689 (95% confidence interval: 0.570, 0.792, p<0.01) at the cutoff value of 86 U/L. Additionally, pleural adenosine deaminase had a sensitivity of 63.2% (46.0-78.2%); a specificity of 73.7% (56.9-86.6%); positive and negative likelihood ratios of 2.18 and 0.50, respectively; and positive and negative predictive values of 70.6% and 66.7%, respectively. CONCLUSIONS: Pleural effusion adenosine deaminase is a helpful alternative biomarker for early and quick discrimination of Gram-negative from Gram-positive bacterial infections of the pleural space, which is useful for the selection of antibiotics.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Adenosine Deaminase/analysis , Clinical Enzyme Tests , Gram-Negative Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/diagnosis , Pleural Effusion/enzymology , Biomarkers/analysis , Diagnosis, Differential , Gram-Negative Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/microbiology , Pleural Effusion/microbiology , Predictive Value of Tests , Retrospective Studies , Sensitivity and Specificity
10.
Article in English | WPRIM | ID: wpr-220501

ABSTRACT

BACKGROUND/AIMS: We investigated the time of onset of antituberculous drug-induced hepatotoxicity (ADIH) and related characteristics. METHODS: Adult patients (n = 1,031) treated with first-line antituberculous drugs between February 2009 and January 2013 were enrolled. RESULTS: Of the 1,031 patients, 108 patients (10.5%) developed ADIH a mean of 39.6 +/- 43.7 days after treatment initiation. Twenty-eight patients (25.9%) developed ADIH within 7 days, 73 (67.6%) within 30 days, and the rest after 30 days. The 30-day group. In subgroup analysis, the 40 IU/L (odds ratio [OR], 2.995; 95% confidence interval [CI], 1.580 to 5.680; p = 0.001) and presence of anti-hepatitis C virus (OR, 4.204; 95% CI, 1.822 to 9.700, p = 0.001) were independent risk factors for development of ADIH. CONCLUSIONS: Approximately 70% of the cases of ADIH occurred in the first month of antituberculous treatment, and were associated with continuation of the first-line drug regimen.


Subject(s)
Adult , Aged , Alanine Transaminase/blood , Antitubercular Agents/adverse effects , Aspartate Aminotransferases/blood , Biomarkers/blood , Chemical and Drug Induced Liver Injury/blood , Chi-Square Distribution , Clinical Enzyme Tests , Coinfection , Drug Monitoring/methods , Drug Therapy, Combination , Early Diagnosis , Female , Hepatitis/complications , Humans , Liver Function Tests , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Predictive Value of Tests , Retrospective Studies , Risk Factors , Time Factors
11.
Rev. Soc. Bras. Clín. Méd ; 13(3)dez. 2015. ilus
Article in Portuguese | LILACS | ID: lil-774724

ABSTRACT

A doença de Fabry é uma enfermidade genética ligada ao cromossomoX e de caráter progressivo, causada pela deficiênciaparcial ou total da enzima alfa galactosidase A (?-Gal A). Habitualmenteo diagnóstico é tardio em função das complicaçõespatológicas provocadas pela deficiência da enzima. OBJETIVO:Neste estudo, descrevemos os aspectos clínicos de um caso familiaratravés do acompanhamento ao longo de 3 anos, duranteo tratamentopela reposição enzimática. MÉTODOS: O métodoadotado foi indutivo, relacionado ao estudo de caso familiarde pacientes com doença de Fabry. Quanto à natureza das informações,a pesquisafoi qualitativa, utilizando-se, quanto aoseu objetivo, à pesquisa exploratória. Com relação as fonte deinformação e procedimento de coleta, a pesquisa caracteriza-secomo sendo bibliográfica e documental. A amostra foi compostapor três pacientesque realizamacompanhamento quinzenalpara aplicação de terapia de reposição enzimática. O critério deinclusão para a pesquisa partiu do pressuposto de se considerarque a doença de Fabry é uma afecção rara e que a família estudadacontempla com riqueza manifestações clínicas, capazesde caracterizar a doença de Fabry. RESULTADOS: Os principaissintomas clínicos relatados pelos pacientes foram: crisede dor generalizada, fadiga, acroparestesia, febre, mialgia, dorabdominal, hipohidrose, intolerância ao frio, calor e ao exercíciofísico. Esses sintomas segundo os pacientes surgiram nainfância e foram amenizados após o uso da terapia de reposiçãoenzimática, propiciando uma melhor qualidade de vida para osmesmos. Também, se observou sinais específicos desta patologianos pacientes, como córnea verticillata e angioqueratoma. Atravésda genotipagem se verificou a semelhança da mutação entre os pacientes do estudo, demonstrando padrão típico de herançarecessiva ligada ao cromossomo X. CONCLUSÃO: Os pacientesdeste estudo apresentaram quadro clínico semelhante,sendoque a sintomatologia iniciou na infância. Córnea verticillata eangioqueratoma umbilical foram sinais encontrados nos pacientes do sexo masculino e são considerados manifestações clínicas frequentes desta patologia. A herança encontrada nesta amostra tem um padrão típico de herança recessiva ligada ao cromossomo X. Desta forma, apesar de ser uma afecção rara na população em geral, o diagnóstico precoce e a terapia de reposição enzimática permitem a evolução clínica favorável e a melhoria da qualidade de vida do paciente.(AU)


Fabry disease is a genetic disorder linked to the X chromosomeand progressive, caused by partial or total deficiency of alphagalactosidase A (?-Gal A). Usually the diagnosis is delayed dueto the pathological complications caused by deficiency of theenzyme. OBJECTIVE: In this study, we describe the clinicalaspects of a family case by monitoring for over three years,during the treatment by enzyme replacement. METHODS:The method adopted was inductive, related to the study of afamily case with patients with Fabry disease. About the nature ofthe information, the research was qualitative, using, as its goal,the exploratory research. Regarding the source of informationand collection procedure, the research is characterized asbibliographical and documentary. The sample was composed ofthree patients submitted to biweekly monitoring for applicationof enzyme replacement therapy. The inclusion criterion forthe research assumed to consider that Fabry disease is a raredisease and that the studied family contemplates with wealththe clinical manifestations, able to characterize the Fabrydisease. RESULTS: The main clinical symptoms related bypatients were: generalized pain crisis, fatigue, acroparesthesia,fever, myalgia, abdominal pain, hypohidrosis, intolerance tocold, heat and exercise. These symptoms according to patientsemerged in childhood and were alleviated after the use ofenzyme replacement therapy, providing a better quality of lifefor them. Also, we found specific signs of this disease in patients,as verticillata cornea and angiokeratoma. By genotyping, it wasfound the similarity of the mutation among patients in thestudy, showing typical pattern of recessive inheritance linkedto chromosome X. CONCLUSION: The patients in this study showed similar clinical condition, and the symptoms began inchildhood. Verticillata cornea and umbilical angiokeratomasigns were found in male patients and are considered commonclinical manifestations of this pathology. The heritage found inthis sample has a typical pattern of recessive inheritance linkedto chromosome X. Thus, despite being a rare disease in generalpopulation, early diagnosis and enzyme replacement therapyallow favorable clinical evolution and improved patient qualityof life.(AU)


Subject(s)
Humans , Glucan 1,4-alpha-Glucosidase/therapeutic use , Fabry Disease/diagnosis , Enzyme Replacement Therapy , Angiokeratoma , Clinical Enzyme Tests/instrumentation , Genotyping Techniques/instrumentation
12.
J. pediatr. (Rio J.) ; 91(5): 442-447, Sept.-Oct. 2015. tab, graf
Article in English | LILACS | ID: lil-766168

ABSTRACT

ABSTRACT OBJECTIVE: Describe the clinical and laboratory profile, follow-up, and outcome of a series of cases of acute viral myositis. METHOD: A retrospective analysis of suspected cases under observation in the emergency department was performed, including outpatient follow-up with the recording of respiratory infection and musculoskeletal symptoms, measurement of muscle enzymes, creatine phosphokinase (CPK), lactate dehydrogenase (LDH), transaminases (AST and ALT), blood count, C-reactive protein, and erythrocyte sedimentation rate in the acute phase and during follow-up until normalization. RESULTS: Between 2000 and 2009, 42 suspected cases were identified and 35 (27 boys) were included. The median age was 7 years and the diagnosis was reported in 89% in the first emergency visit. The observed respiratory symptoms were cough (31%), rhinorrhea (23%), and fever (63%), with a mean duration of 4.3 days. Musculoskeletal symptoms were localized pain in the calves (80%), limited ambulation (57%), gait abnormality (40%), and muscle weakness in the lower limbs (71%), with a mean duration of 3.6 days. There was significant increase in CPK enzymes (5507 ± 9180 U/L), LDH (827 ± 598 U/L), and AST (199 ± 245 U/L), with a tendency to leukopenia (4590 ± 1420) leukocytes/mm3. The complete recovery of laboratory parameters was observed in 30 days (median), and laboratory and clinical recurrence was documented in one case after 10 months. CONCLUSION: Typical symptoms with increased muscle enzymes after diagnosis of influenza and self-limited course of the disease were the clues to the diagnosis. The increase in muscle enzymes indicate transient myotropic activity related to seasonal influenza, which should be considered, regardless of the viral identification, possibly associated with influenza virus or other respiratory viruses.


RESUMO OBJETIVO: Descrever o perfil clínico-laboratorial, o acompanhamento e o desfecho de uma série de casos de miosite aguda viral. MÉTODO: Foi conduzida uma análise retrospectiva de casos suspeitos, em observação em unidade de emergência, e seguimento ambulatorial com o registro de sintomas de infecção respiratória, sintomas músculo-esqueléticos, determinação de enzimas musculares, creatina-fosfoquinase (CPK), desidrogenase lática (DHL), transaminases (AST e ALT), hemograma, proteína C reativa e velocidade de hemossedimentação, na fase aguda e no acompanhamento, até a normalização. RESULTADOS: Entre 2000 e 2009, 42 casos suspeitos foram identificados e 35 (27 meninos) foram incluídos. A mediana de idade foi de sete anos e o diagnóstico relatado em 89%, na primeira visita de emergência. Os sintomas respiratórios observados foram: tosse (31%), coriza (23%) e febre (63%), com duração média de 4,3 dias. Os sintomas músculo-esqueléticos foram: dor localizada nas panturrilhas (80%), deambulação limitada (57%), marcha anormal (40%) e fraqueza muscular nos membros inferiores (71%), com duração média de 3,6 dias. Observou-se elevação importante das enzimas CPK (5.507 ± 9.180) U/l, DHL (827 ± 598) U/l e AST (199 ± 245) U/l e tendência a leucopenia (4.590 ± 1.420) leucócitos/mm3. A recuperação completa dos parâmetros laboratoriais foi observada em 30 dias (mediana) e a recaída clínica e laboratorial em um caso após 10 meses. CONCLUSÃO: Os sintomas típicos com enzimas musculares elevadas após diagnóstico de influenza e o curso autolimitado foram os indícios para o diagnóstico. A elevação de enzimas musculares indica a atividade miotrópica transitória relacionada à influenza sazonal que deve ser considerada, a despeito da identificação viral, possivelmente associada com o vírus influenza ou outros vírus respiratórios.


Subject(s)
Child , Child, Preschool , Female , Humans , Male , Myositis/virology , Virus Diseases/complications , Acute Disease , C-Reactive Protein/analysis , Clinical Enzyme Tests/methods , Creatine Kinase, MB Form/blood , Creatine Kinase/blood , Influenza, Human/complications , Muscle Weakness/etiology , Myositis/diagnosis , Retrospective Studies , Sex Distribution , Time Factors , Transaminases/blood , Virus Diseases/diagnosis
13.
Pesqui. vet. bras ; 35(9): 795-800, Sept. 2015. graf
Article in Portuguese | LILACS | ID: lil-767738

ABSTRACT

A indoleamina 2,3-dioxigenase (IDO) é uma enzima responsável por catabolizar o aminoácido triptofano. Sua presença no ambiente uterino placentário está relacionada à tolerância imunológica ao semi-aloenxerto, pois impede a proliferação de células imunológicas maternas, seja pela falta do aminoácido, ou pela ação de alguns catabólitos oriundos da quebra do triptofano, como o ácido quinolínico, que é tóxico principalmente para os linfócitos T. Pouco se conhece sob a influência de substâncias (hormônios e citocinas) presentes na interface materno fetal e a expressão dessa enzima. Por esta razão, formulou-se a hipótese de que hormônios e interleucinas presentes na região uteroplacentária poderiam exercer algum efeito na expressão da IDO. Células oriundas da interface materno fetal de ratas Wistar foram mantidas em cultivo, onde receberam suplementação com estradiol e interferon-γ. A expressão da enzima foi avaliada pela técnica de citometria de fluxo nos períodos de 4, 24 e 48 horas e confirmação da presença proteica por imuno-histoquímica. Os resultados mostraram um aumento na expressão de IDO após a adição de estrógeno (9,03±0,81/11,25±0,25) e interferon-γ (9,03±0,81/20,43±0,60). O efeito do interferon-γ já era esperado como relatado na literatura, contudo, a elevação da expressão da IDO pela adição do estrógeno constitui nova informação sobre possíveis mecanismos envolvidos na ativação da enzima. O melhor esclarecimento desses achados poderia contribuir para uma melhor compreensão da participação dessa enzima na tolerância materno-fetal e para uma futura modulação terapêutica da mesma...


The indoleamine 2,3-dioxygenase (IDO) is an enzyme responsible for catabolizing the tryptophan. Its presence in the placental uterine environment is related to immunological tolerance to the semi-allograft because it prevents proliferation of maternal immune cells, either by the lack of this amino acid or by the action of its catabolites, such as the quinolinic acid, which is particularly toxic for T lymphocytes. Little is known regarding the influence of hormones and cytokines on the expression of IDO in the maternal fetal interface. Therefore, the hypothesis that some hormones and interleukins present in uteroplacental region could have an effect on the expression of IDO on cultured cells was tested. Cells derived from the fetal maternal interface from Wistar rats were kept in culture and supplemented with estradiol and interferon-γ. Expression of the enzyme was assessed by flow cytometry at periods of 4, 24 and 48 hours and confirmation of the presence of protein by immunohistochemistry. The results showed an increasing of IDO expression after the addition of estrogen (9.03±0.81 to 11.25±0.25) and interferon-γ (9.03±0.81 to 20.43±0.60). The effect of interferon-γ was expected as reported in the literature, however, elevated IDO expression by estrogen represents new information on possible mechanisms involved in the enzyme activation. These findings could provide a better understanding of IDO contribution on maternal-fetal tolerance and may collaborate to future therapeutic modulation of this enzyme...


Subject(s)
Animals , Female , Pregnancy , Guinea Pigs , Estrogens , Interferon-gamma , Rats, Wistar/embryology , Flow Cytometry/veterinary , Clinical Enzyme Tests/veterinary , Immunohistochemistry/veterinary , Placenta
14.
Gut and Liver ; : 641-648, 2015.
Article in English | WPRIM | ID: wpr-216105

ABSTRACT

BACKGROUND/AIMS: M2 pyruvate kinase (M2-PK) is an enzyme that is produced in undifferentiated and proliferating tissues. This study aims to evaluate the usefulness of the immunochromatographic M2 pyruvate kinase (iM2-PK) for the screening of colorectal cancer (CRC) and premalignant lesions. METHODS: Healthy volunteers and patients with colorectal neoplasia were enrolled in six academic hospitals in the capital province of Korea. The iM2-PK value was compared with the immunochromatographic fecal occult blood test (iFOBT) and fecal tumor M2-PK enzyme-linked immunosorbent assay (ELISA). RESULTS: A total of 323 subjects were enrolled. The sensitivity of iM2-PK for CRC was 92.8%, which was superior to iFOBT (47.5%, p<0.0001). For adenomatous lesions, the sensitivity of iM2-PK was 69.4%, which was also superior to iFOBT (12.1%, p<0.001). Compared with M2-PK ELISA, iM2-PK exhibited significantly enhanced sensitivity for CRC (97.5% vs 80.0%, p=0.0289). The sensitivity of iM2-PK was higher in advanced stages of CRC compared with cancers confined to the mucosa and submucosa (p<0.05). However, lymph node metastasis had no influence on the sensitivity of iM2-PK. CONCLUSIONS: The iM2-PK exhibited increased sensitivity for identifying CRC and adenomatous lesions compared with iFOBT. Given its rapid results and convenience, CRC screening using iM2-PK is promising.


Subject(s)
Adenoma/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Clinical Enzyme Tests/instrumentation , Colorectal Neoplasms/diagnosis , Enzyme-Linked Immunosorbent Assay , Feces/enzymology , Female , Healthy Volunteers , Humans , Chromatography, Affinity/methods , Male , Middle Aged , Occult Blood , Precancerous Conditions/diagnosis , Predictive Value of Tests , Pyruvate Kinase/analysis , Reagent Kits, Diagnostic , Republic of Korea , Sensitivity and Specificity
15.
Acta bioquím. clín. latinoam ; 48(2): 183-189, jun. 2014. graf, tab
Article in Spanish | LILACS | ID: lil-734226

ABSTRACT

El laboratorio debe garantizar la exactitud de los resultados de HbA1c cumpliendo con los requisitos analíticos internacionales de calidad, cada vez más estrictos y asegurar que una variación de HbA1c de 0,5 puntos porcentuales (%-NGSP) o más entre dos controles consecutivos de un paciente diabético se deba a una variación clínica y no a una variación analítica. En este trabajo se evaluó el desempeño analítico de tres métodos comerciales para HbA1c: inmunoturbidimétrico, enzimático y cromatográfico de intercambio catiónico. Para tal fin, se procesaron por cada método distintos controles comerciales de HbA1c, con trazabilidad al método de referencia IFCC, determinándose en cada caso Coeficiente de Variación Total, Bias, Error Total, Valor de Referencia del Cambio y cambio clínico significativo de HbA1c en el punto crítico 7,0%-NGSP. En las condiciones analíticas de este trabajo, solamente el método inmunoturbidimétrico tuvo un desempeño analítico aceptable, permitiendo atribuir un cambio de 0,5%-NGSP a una variación clínica significativa del paciente. Frente a las recomendaciones internacionales sobre el uso de HbA1c en el control y diagnóstico de diabetes, es indiscutible la importancia de elegir un método que satisfaga los requerimientos analíticos mínimos de calidad para asegurar la utilidad clínica del resultado de HbA1c.


The laboratory must guarantee the accuracy of HbA1c results meeting the increasingly strict international analytical quality standards and assuring that an HbA1c variation of 0.5 percentage points (%-NGSP) or more between two consecutive controls of a diabetic patient is due to a clinical variation and not to an analytical variation. In this paper, the analytical performance of three commercial methods for HbA1c: Immunoturbidimetric, Chromatographic and Enzymatic Cation Exchange, were evaluated. For this purpose, commercial controls with assigned values traceable to the IFCC reference method for HbA1c were processed. For each methodology, total Coefficient of Variation (CV%), Bias%, Total Error (TE%), Change Reference Value and Clinically Significant Change (CSC) at the critical point of HbA1c 7.0%-NGSP were determined. Within the analytical conditions of this study, only the immunoturbidimetric method had an acceptable analytical performance, allowing attribute a change in 0.5%-NGSP to a significant clinical variation. Faced with international recommendations on the use of HbA1c on control and diagnosis of diabetes, the importance of choosing a method that meets the minimum analytical quality requirements to ensure the clinical utility of HbA1c result is undeniable.


O laboratório deve garantir a precisão dos resultados da HbA1c cumprindo com os requisitos analíticos internacionais de qualidade cada vez mais exigentes e garantir que uma variação de HbA1c de 0,5 pontos percentuais (% - NGSP) ou mais entre duas verificações consecutivas de um doente diabético seja devido a uma variação clínica e não a uma variação analítica. Neste trabalho foi avaliado o desempenho analítico de três métodos comerciais para HbA1c: imunoturbidimétrico, enzimático e cromatográfico de intercâmbio catiônico. Para esse fim, foram processados diversos controles comerciais de HbA1c por cada método, com rastreabilidade ao método de referência IFCC, determinando em cada caso Quociente de Variação Total, Bias, Erro Total, Valor de Referência da Alteração e Alteração Clinicamente Significativa de HbA1c no ponto crítico 7,0%-NGSP. Nas condições de análise deste estudo, apenas o método imunoturbidimétrico teve um desempenho analítico aceitável, permitindo atribuir uma alteração de 0,5%-NGSP a uma variação clínica significativa do paciente. Perante as recomendações internacionais sobre o uso da HbA1c no controle e diagnóstico da diabetes, é inegável a importância de escolher um método que atenda os requisitos analíticos mínimos de qualidade de análise para garantir a utilidade clínica do resultado HbA1c.


Subject(s)
Humans , Analytical Quality Control/methods , Clinical Laboratory Techniques/standards , Chemistry Techniques, Analytical , Chromatography/standards , Clinical Enzyme Tests/standards , Diabetes Mellitus/diagnosis , Hemoglobin A , Immunoturbidimetry/standards , Quality Control
16.
Clin. biomed. res ; 34(1): 47-52, 2014. tab
Article in Portuguese | LILACS | ID: biblio-834451

ABSTRACT

INTRODUÇÃO: A disseminação de Klebsiella pneumoniae carbapenemase (KPC) no Brasil e a recente detecção de bactérias produtoras de New Delhi metalo-β-lactamase (NDM-1) em hospital terciário do sul do Brasil indicam a necessidade da avaliação da presença destas enzimas em enterobactérias resistentes a carbapenêmicos (ERC).OBJETIVO: Avaliar prevalência de carbapenemases nas ERC em quatro hospitais terciários de Porto Alegre, por meio de PCR multiplex em tempo real. MÉTODOS: Estudo descritivo, período de abril a dezembro de 2013. Isolados bacterianos de pacientes internados foram identificados pelo sistema automatizado VITEK 2, com realização do teste de suscetibilidade aos antimicrobianos. Amostras com isolados de ERC foram encaminhadas ao laboratório de referência para análise por PCR em tempo real para identificação de carbapenemases. RESULTADOS: Total de 701 isolados. As ERC predominantes foram K. pneumoniae (47% das amostras positivas) e Enterobacter cloacae (18%). As carbapenemases mais frequentes foram KPC (48%), OXA-48-like (3%) e NDM (2%). Em 47% das amostras não foi identificado o mecanismo de resistência. Isolados originados de culturas de vigilância foram associados com maior positividade para carbapenemases do que isolados de amostras clínicas (p<0,0001). Isolados de ERC pertencentes ao grupo Proteae (Proteus spp., Morganella spp., Providencia spp.) foram associados a menor positividade para carbapenemase do que isolados de outras ERC (p<0,0001). CONCLUSÃO: KPC foi a carbapenemase mais frequentemente detectada. A circulação de uma enzima OXA-48-like foi demonstrada, um achado novo e preocupante. O achado da carbapenemase NDM também é preocupante devido ao seu potencial de disseminação. Esses dados e outros estudos poderão contribuir para um entendimento maior da epidemiologia das ERC.


BACKGROUND: The spread of Klebsiella pneumoniae carbapenemase (KPC) in Brazil and the recent detection of bacteria producing New Delhi metallo-β-lactamase (NDM-1) in a tertiary care hospital in Porto Alegre indicate the need to evaluate the presence of these enzymes in carbapenem-resistant Enterobacteriaceae (CRE). AIM: To evaluate the prevalence of carbapenemases in CRE in four tertiary care hospitals in Porto Alegre using multiplex real-time PCR.METHODS: Descriptive study from April to December 2013. Bacterial isolates from hospitalized patients were identified by VITEK 2 automated system, with antimicrobial susceptibility testing. Samples with CRE isolates were sent to the reference laboratory for analysis using real-time PCR for identification of carbapenemases. RESULTS: Total of 701 isolates. The predominant CRE were K. pneumoniae (46% of positive samples) and Enterobacter cloacae (18%). The most frequent carbapenemases were KPC (48%), OXA-48-like (3%), and NDM-1 (2%). In 47% of the samples no carbapenemase was identified. Isolates originated from surveillance cultures were associated with higher positivity for carbapenemases than isolates from clinical samples (p<0.0001). CRE isolates belonging to the Proteae group (Proteus spp., Morganella spp., Providencia spp.) were associated with less positivity for carbapanemase than isolates of other CRE (p<0.0001). CONCLUSION: KPC was the most frequently detected carbapenemase. The movement of an OXA-48-like enzyme was demonstrated, a novel and worrisome finding. The finding of carbapenemase NDM is also worrisome due to its dissemination potential. These data and further studies may contribute to a better understanding of the epidemiology of CRE.


Subject(s)
Carbapenems/antagonists & inhibitors , Drug Resistance, Bacterial , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/microbiology , Bacterial Proteins/isolation & purification , Cross-Sectional Studies , Clinical Enzyme Tests/methods , Bacterial Proteins/analysis , Multiplex Polymerase Chain Reaction , Real-Time Polymerase Chain Reaction
17.
Clinics ; 69(12): 799-803, 2014. tab, graf
Article in English | LILACS | ID: lil-732392

ABSTRACT

OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference could not be used to discriminate between the two. The objective of the present study was to investigate the levels of superoxide dismutase 2 in pleural effusions and to evaluate the diagnostic significance of pleural effusion superoxide dismutase 2. METHODS: Superoxide dismutase 2 concentrations were determined in pleural effusions from 54 patients with tuberculous pleural effusion and 33 with malignant pleural effusion using an enzyme-linked immunosorbent assay (ELISA) kit. Pleural effusion interferon gamma and tumor necrosis factor alpha levels were also analyzed by ELISA. The Mann-Whitney U test was used to evaluate the significance of differences. Associations between superoxide dismutase 2 concentrations and sex, age and smoking habits were assessed using Spearman's or Pearson's correlation coefficient analysis. Receiver operator characteristic analysis was performed to evaluate the value of superoxide dismutase 2 levels in the discrimination of tuberculous pleural effusion from malignant pleural effusion. RESULTS: Superoxide dismutase 2 levels were significantly higher in patients with tuberculous pleural effusion compared with those with malignant pleural effusion ...


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Clinical Enzyme Tests , Pleural Effusion, Malignant/diagnosis , Pleural Effusion/diagnosis , Superoxide Dismutase/analysis , Tuberculosis, Pleural/diagnosis , Biopsy , Biomarkers/analysis , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Interferon-gamma/analysis , Retrospective Studies , ROC Curve , Reactive Oxygen Species/metabolism , Statistics, Nonparametric , Tumor Necrosis Factor-alpha/analysis
18.
Indian J Exp Biol ; 2013 Oct; 51(10): 777-788
Article in English | IMSEAR | ID: sea-149382

ABSTRACT

Enzymes are biocatalysts and because of their remarkable properties, they are extensively used in medical diagnosis. Researches in the last two decades have concentrated more on enzymes such as creatine kinase–MB, alanine transaminase, aspartate transaminase, acid phosphatase, alkaline phosphatase etc. for clinical applications. Enzymes are the preferred markers in various disease states such as myocardial infarction, jaundice, pancreatitis, cancer, neurodegenerative disorders, etc. They provide insight into the disease process by diagnosis, prognosis and assessment of response therapy. Even though the literature on the use of enzymes in various disease conditions has accumulated, a comprehensive analysis is lacking and hence this review.


Subject(s)
Biomarkers/analysis , Biomarkers/blood , Biosensing Techniques , Clinical Enzyme Tests/methods , Diagnostic Techniques and Procedures , Enzymes/analysis , Enzymes/blood , Humans
19.
J. bras. med ; 101(5): 21-23, set.-out. 2013.
Article in Portuguese | LILACS | ID: lil-706142

ABSTRACT

Atualmente o diagnóstico de tuberculose pleural pode ser realizado com a dosagem de biomarcadores diagnósticos no líquido pleural, especificamente com a dosagem da enzima adenosina desaminase. Os quadros clínico, laboratorial, imagem e citopatologia sugestivos sempre devem ser valorizados no conjunto do diagnóstico. Tal abordagem elege somente o procedimento de toracocentese como necessário para início do diagnóstico. Na maioria das apresentações clínicas, procedimentos cirúrgicos mais invasivos (biopsias pleurais), com complicações potencialmente fatais, não precisam ser realizados para exame histopatológico


Currently the diagnosis of pleural tuberculosis can be performed with the dosage of diagnostic biomarkers in pleural fluid, specifically the enzyme adenosine deaminase. The clinical, imaging and cytology suggestive should always be valued in the set of diagnosis together laboratory measurements. This approach selects only a thoracentesis procedure for early diagnosis. In most clinical presentations, more invasive surgical procedures (pleural biopsies) with life-threatening complications for histopathological examination


Subject(s)
Humans , Male , Female , Pleural Effusion/diagnosis , Pleural Effusion/enzymology , Biomarkers/analysis , Adenosine Deaminase/analysis , Diagnostic Techniques and Procedures , Clinical Enzyme Tests/methods , Interferon-gamma/analysis , Paracentesis/methods , Tuberculosis, Pleural/diagnosis
20.
Lima; s.n; 2013. 104 p. ilus, tab, graf.
Thesis in Spanish | LIPECS, LILACS, LIPECS | ID: lil-707822

ABSTRACT

OBJETIVO: Comparar los métodos de ELISA e IFI para la detección de la Enfermedad de Chagas en muestras seropositivas del Banco de Sangre del Hospital Nacional Guillermo Almenara Irigoyen en el 2010. MATERIAL y METODOS: Se realizó un estudio descriptivo retrospectivo en 22,589 donantes de Banco de Sangre del Hospital Guillermo Almenara Irigoyen durante el año 2010, para lo cual se realizó el test de ELISA (Chagas biokit). La muestra de estudio estuvo constituida por el total de donantes reactivos e indeterminados para el ELISA (N=183), a los cuales se les realizó un segundo ensayo, y para los casos no concordantes entre el1er y 2do ELISA se le realizó un tercer ensayo y posteriormente se les realizó inmunofluorescencia indirecta (IFI) para Chagas, Se recolectaron datos sociodemográficos de los donantes como edad, sexo y procedencia. Los datos fueron registrados en una base de datos; y analizada; con el programa Excel para Macintosh. RESULTADOS: Se analizaron 183 casos, 134 eran de sexo masculino (73.2 por ciento). La proporción de donantes reactivos confirmados para enfermedad de Chagas fue de 2.2 por 10,000 en el Hospital Nacional Guillermo Almenara Irigoyen en el año 2010. La edad promedio de los donantes reactivos fue de 35.7 años. El antecedente de donación previa estuvo presente sólo en el 2.2 por ciento. La mayoría de los donantes era procedente de la provincia de Lima (157; 85.5 por ciento). El 87.4 por ciento (160) de los sueros fueron reactivos en el 1er ELISA, 54.6 por ciento (100) en el 2do ELISA, 57.4 por ciento en el resultado final ELISA y sólo el 2.7 por ciento en IFI y el goldstandard. La tasa de concordancia entre el ELISA e IFI fue del 31.1 por ciento (57). Todos los casos confirmados con la prueba goldstandard fueron del sexo masculino, y la edad promedio fue de 27.2 años. Sólo el 5 por ciento de los sueros reactivos para Chagas con la prueba de ELISA fueron realmente reactivos cuando se utilizó el goldstandard...


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Chagas Disease/diagnosis , Clinical Enzyme Tests , Hematologic Tests , Public Health , Fluorescent Antibody Technique, Indirect , Retrospective Studies , Cross-Sectional Studies , Observational Studies as Topic
SELECTION OF CITATIONS
SEARCH DETAIL